BioCryst Pharmaceuticals, Inc. (BCRX)
6.615
-0.04
(-0.68%)
USD |
NASDAQ |
Jan 20, 15:01
BioCryst Pharmaceuticals Free Cash Flow: 47.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Astria Therapeutics, Inc. | -120.32M |
| Hologic, Inc. | 904.70M |
| Bruker Corp. | -10.60M |
| Viatris, Inc. | 1.614B |
| KalVista Pharmaceuticals, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 41.11M |
| Cash from Investing (Quarterly) | 13.57M |
| Cash from Financing (Quarterly) | -58.30M |
| Free Cash Flow Per Share (Quarterly) | 0.1809 |
| Free Cash Flow to Equity (Quarterly) | 95.58M |
| Free Cash Flow to Firm (Quarterly) | 60.67M |
| Free Cash Flow Yield | 3.34% |